Dr. Barry Dworkin

  • About
  • Radio Interviews
    • Wednesday House Call
    • Sunday House Call Shows
  • Articles
    • Health Headlines
    • Prevention and Screening
    • Clinical Research
    • Health Policy
    • Cancer/Oncology
    • Neurology
  • A preprint, non-peer-reviewed study states that weight-loss drugs such as Wegovy are more likely to cause temporary hair loss compared to Contrave. The latter is not overly efficacious hence less weight loss therefore less hair loss.

    March 18, 2025

    Medical Mythbusting Commentary for March 18, 2025 Source:Weight-Loss Drugs Like Wegovy Are Linked to Hair Loss Reference:Risk of Hair Loss with Semaglutide for Weight Loss

  • Wegovy (semaglutide) now approved by Health Canada to reduce the risk of non-fatal heart attack in people with known cardiovascular disease in addition to its use for weight loss management.

    November 28, 2024

    Medical Mythbusting Commentary for November 28, 2024 Source:Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk

  • Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.

    July 4, 2024

    Medical Mythbusting Commentary for July 4, 2024 Source:Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness

  • Wegovy (semaglutide) approved by FDA to support people struggling to lose weight (and that includes many). Health Canada did so in November 2021. Major addition to weight-loss management options.

    June 8, 2022

    Medical Mythbusting Commentary for June 8, 2022 Source:Weight-loss drug called Wegovy receives FDA approval

  • Treatments for weight loss do exist, work well for many, and reveal our growing understanding of how our homeostatic, motivational, and executive brain centers interact with respect to weight control.

    May 11, 2022

    Medical Mythbusting Commentary for May 11, 2022 Source:People Taking New Hunger-Blocking Drug Lose 24 Kilograms On Average

  • Facebook
  • X